Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Headache|August 14, 2009
Occipital nerve blocks: when and what to inject?Joshua Tobin, Stephen Flitman
Headache|January 5, 2011
Treatment of migraine with occipital nerve blocks using only corticosteroidsJoshua Tobin, Stephen Flitman
IEEE Transactions on Pattern Analysis and Machine Intelligence|October 25, 2023
A Theoretical Analysis of Density Peaks Clustering and the Component-Wise Peak-Finding AlgorithmJoshua Tobin, Mimi Zhang
Journal of the American Medical Directors Association|January 11, 2007
A multi-center blinded prospective study of urine neural thread protein measurements in patients with suspected Alzheimer's diseaseIra Goodman, Greg Golden, Stephen Flitman, et al.
Oncotarget|May 29, 2018
A high LDH to absolute lymphocyte count ratio in patients with DLBCL predicts for a poor intratumoral immune response and inferior survivalColm Keane, Joshua Tobin, Dipti Talaulikar, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 26, 2026
Low fixed dose rasburicase for tumour lysis syndrome prophylaxis and treatment is feasible and efficacious in the management of haematologic malignanciesTaylor Mackie, Joshua Tobin, Vivien Chan, et al.
BMC Neurology|April 24, 2021
Efficacy of galcanezumab in patients with migraine who did not benefit from commonly prescribed preventive treatmentsDulanji K Kuruppu, Joshua Tobin, Yan Dong, et al.
Pathology|November 24, 2022
Diffuse large B-cell lymphoma and red cell autoimmunity: clinical role and pathogenesisCaitlin Coombes, Keisuke Horikawa, Sanjiv Jain, et al.
Cephalalgia : an International Journal of Headache|November 21, 2019
Lasmiditan for the acute treatment of migraine: Subgroup analyses by prior response to triptansKerry Knievel, Andrew S Buchanan, Louise Lombard, et al.
Journal of Medical Economics|May 5, 2022
Annual indirect cost savings in patients with episodic or chronic migraine: post-hoc analyses from multiple galcanezumab clinical trialsJoshua Tobin, Janet H Ford, Antje Tockhorn-Heidenreich, et al.
Pageof 2